Florbetaben (18F)

Florbetaben (18F) is a radiopharmaceutical compound used in positron emission tomography (PET) imaging. It is a derivative of the benzothiazole chemical group and is specifically used for the detection of beta-amyloid plaques in the brain, which are a hallmark of Alzheimer's disease.

Chemistry[edit | edit source]

Florbetaben (18F) is a fluorine-18 labeled stilbene derivative. The compound is designed to bind to beta-amyloid plaques in the brain, which can then be detected using PET imaging. The fluorine-18 isotope acts as a radioactive tracer, emitting positrons that can be detected by the PET scanner.

Medical Use[edit | edit source]

Florbetaben (18F) is used in PET imaging to detect the presence of beta-amyloid plaques in the brain. These plaques are a characteristic feature of Alzheimer's disease and their detection can aid in the diagnosis of this condition. The compound is injected into the bloodstream and travels to the brain, where it binds to the plaques. The fluorine-18 isotope then emits positrons, which are detected by the PET scanner to create an image of the brain.

Safety and Efficacy[edit | edit source]

The safety and efficacy of Florbetaben (18F) have been evaluated in several clinical trials. The compound has been shown to be safe for use in humans, with no serious adverse events reported. In terms of efficacy, Florbetaben (18F) has been shown to accurately detect beta-amyloid plaques in the brain, with a high degree of sensitivity and specificity.

Regulation[edit | edit source]

Florbetaben (18F) is regulated by the Food and Drug Administration (FDA) in the United States and the European Medicines Agency (EMA) in Europe. It is approved for use in PET imaging for the detection of beta-amyloid plaques in the brain.